Internal Medicine Doctors in Ada, MI Accepting Medicare

5 Internal Medicine doctors found. Showing 1 - 5

Dr. Ashley Barcroft, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7128 Fulton St E, Ada, MI 49301 Phone: 616-825-3530

Richard Lovy, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5007 Meadow Springs Trl Se, Ada, MI 49301 Phone: 616-719-2293

Andrew Lewandoski, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6741 Fulton St E, Ada, MI 49301 Phone: 616-320-5330    Fax: 616-320-5331

Dr. Peter C Lenhart, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6741 E Fulton St, Ste 201, Ada, MI 49301 Phone: 616-685-2500    Fax: 616-685-2511

Dr. James Douglas Birmingham, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6741 Fulton St E, Ada, MI 49301 Phone: 616-320-5330    Fax: 616-320-5331

News Archive

Study: Measles outbreaks may become more frequent if vaccination rates continue to decline

In 2000, measles was declared to be eliminated in the United States, when no sustained transmission of the virus was seen in this country for more than 12 months.

Research: Chronic sleep deprivation linked to heart failure

Poor sleep doubles hospitalisations in heart failure, according to new research in nearly 500 patients presented today at EuroHeartCare 2014.

Healthy People 2020 targets barriers to breastfeeding

For the first time, the barriers to breastfeeding are being addressed at the highest level of government. With the release today of Healthy People 2020, the U.S. Department of Health and Human Services has targeted the new 10-year goals for our nation's health - and supporting breastfeeding is prominent among them.

Antiviral compound GC-376 shows efficacy against SARS-CoV-2 in vivo

Over the past months, many potential antivirals against SARS-CoV-2 have been identified as deserving further development to target several viral proteins. A new study deals with one such molecule, the viral main protease (Mpro) inhibitor GC-376, and describes its efficacy in inhibiting virus-host interaction.

AMSURG acquires Sheridan Healthcare in cash and stock transaction valued at $2.35 billion

AMSURG Corp. and Sheridan Healthcare, a portfolio company of Hellman & Friedman, LLC, today announced that their respective Boards of Directors have unanimously approved a definitive agreement under which AMSURG will acquire Sheridan Healthcare in a cash and stock transaction valued at approximately $2.35 billion.

Read more Medical News

› Verified 3 days ago